跳转至内容
Merck
CN
所有图片(1)

文件

安全信息

Y0001555

Ciclesonide impurity B

European Pharmacopoeia (EP) Reference Standard

别名:

Desisobutyryl-ciclesonide, (2′R)-2′-Cyclohexyl-11b,21-dihydroxy-16bH-[1,3]dioxolo[4′,5′:16,17]pregna-1,4-diene-3,20-dione

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C28H38O6
CAS号:
161115-59-9
分子量:
470.60
UNSPSC代码:
41116107
NACRES:
NA.24

生物来源

synthetic

等级

pharmaceutical primary standard

Agency

EP

API类

ciclesonide

形式

powder

包装

pkg of 10 mg

制造商/商品名称

EDQM

储存条件

protect from light

溶解性

water: <0.1 g/L

应用

pharmaceutical (small molecule)

格式

neat

运输

ambient

储存温度

2-8°C

InChI

1S/C28H38O6/c1-26-11-10-18(30)12-17(26)8-9-19-20-13-23-28(22(32)15-29,27(20,2)14-21(31)24(19)26)34-25(33-23)16-6-4-3-5-7-16/h10-12,16,19-21,23-25,29,31H,3-9,13-15H2,1-2H3/t19-,20-,21-,23+,24+,25+,26-,27-,28+/m0/s1

InChI key

OXPLANUPKBHPMS-ZXBNPROVSA-N

相关类别

一般描述

Ciclesonide impurity B is an impurity of ciclesonide, a new-generation, non-halogenated glucocorticoid.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets, have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

应用

Ciclesonide impurity B is used as an EP reference standard to quantify the analyte in pharmaceutical formulations by liquid chromatography (LC) technique.

包装

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他说明

Sales restrictions may apply.

法规信息

新产品

Choose from one of the most recent versions:

分析证书(COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

New Drugs for Asthma, Allergy and COPD, 42, 42-54 (2001)
Rethinking Cleaning Validation for API Manufacturing
Zhang C, et al.
Pharmaceutical Technology, 42, 42-54 (2018)
Pharmacokinetics of [14 C] ciclesonide after oral and intravenous administration to healthy subjects
Nave R, et al.
Clinical Pharmacokinetics, 43, 479-486 (2004)
Ciclesonide
European Pharmacopoeia Commission and European Directorate for the Quality of Medicines & Healthcare
European pharmacopoeia, 43, 2206-2207 (2017)

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门